EUR 265.5
(-2.85%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 21.63 Billion EUR | -3.49% |
2022 | 22.41 Billion EUR | -4.78% |
2021 | 23.54 Billion EUR | 20.59% |
2020 | 19.52 Billion EUR | 13.15% |
2019 | 17.25 Billion EUR | 15.05% |
2018 | 14.99 Billion EUR | 252.82% |
2017 | 4.25 Billion EUR | -30.43% |
2016 | 6.1 Billion EUR | 3.91% |
2015 | 5.87 Billion EUR | 6.33% |
2014 | 5.52 Billion EUR | 56.36% |
2013 | 3.53 Billion EUR | 18.4% |
2012 | 2.98 Billion EUR | 10.59% |
2011 | 2.7 Billion EUR | 24.51% |
2010 | 2.16 Billion EUR | 51.69% |
2009 | 1.42 Billion EUR | -15.95% |
2008 | 1.7 Billion EUR | 26.45% |
2007 | 1.34 Billion EUR | 10.48% |
2006 | 1.21 Billion EUR | -9.01% |
2005 | 1.33 Billion EUR | 7.55% |
2004 | 1.24 Billion EUR | -3.21% |
2003 | 1.28 Billion EUR | 36.25% |
2002 | 943.58 Million EUR | 0.37% |
2001 | 940.08 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 21.86 Billion EUR | 0.0% |
2023 Q2 | 21.86 Billion EUR | 0.0% |
2023 FY | 21.63 Billion EUR | -3.49% |
2023 Q4 | 21.63 Billion EUR | 0.0% |
2022 Q2 | 24.78 Billion EUR | 0.0% |
2022 FY | 22.41 Billion EUR | -4.78% |
2022 Q4 | 22.41 Billion EUR | 0.0% |
2021 Q2 | 19.39 Billion EUR | 0.0% |
2021 FY | 23.54 Billion EUR | 20.59% |
2021 Q4 | 23.43 Billion EUR | 0.0% |
2020 Q4 | 19.52 Billion EUR | 0.0% |
2020 FY | 19.52 Billion EUR | 13.15% |
2020 Q2 | 19.68 Billion EUR | 0.0% |
2019 FY | 17.25 Billion EUR | 15.05% |
2019 Q2 | 13.89 Billion EUR | 0.0% |
2019 Q4 | 17.25 Billion EUR | 0.0% |
2018 Q2 | 5.6 Billion EUR | 0.0% |
2018 FY | 14.99 Billion EUR | 252.82% |
2018 Q4 | 14.99 Billion EUR | 0.0% |
2017 Q4 | 4.25 Billion EUR | 0.0% |
2017 FY | 4.25 Billion EUR | -30.43% |
2017 Q2 | 6.14 Billion EUR | 0.0% |
2016 FY | 6.1 Billion EUR | 3.91% |
2016 Q2 | 5.87 Billion EUR | 0.0% |
2016 Q4 | 6.1 Billion EUR | 0.0% |
2015 FY | 5.87 Billion EUR | 6.33% |
2015 Q4 | 5.87 Billion EUR | 0.0% |
2015 Q2 | 5.87 Billion EUR | 0.0% |
2014 Q2 | 5.55 Billion EUR | 0.0% |
2014 Q4 | 5.52 Billion EUR | 0.0% |
2014 FY | 5.52 Billion EUR | 56.36% |
2013 FY | 3.53 Billion EUR | 18.4% |
2013 Q4 | 3.53 Billion EUR | 0.0% |
2013 Q2 | 3.14 Billion EUR | 0.0% |
2012 FY | 2.98 Billion EUR | 10.59% |
2012 Q2 | 3.07 Billion EUR | 312.08% |
2012 Q1 | 746.62 Million EUR | -72.35% |
2012 Q4 | 2.98 Billion EUR | 300.0% |
2012 Q3 | 746.62 Million EUR | -75.73% |
2011 Q2 | 2.35 Billion EUR | 248.34% |
2011 FY | 2.7 Billion EUR | 24.51% |
2011 Q4 | 2.7 Billion EUR | 300.0% |
2011 Q3 | 675.1 Million EUR | -71.29% |
2011 Q1 | 675.1 Million EUR | -68.87% |
2010 FY | 2.16 Billion EUR | 51.69% |
2010 Q3 | 542.21 Million EUR | -78.17% |
2010 Q1 | 542.21 Million EUR | -62.08% |
2010 Q4 | 2.16 Billion EUR | 300.0% |
2010 Q2 | 2.48 Billion EUR | 358.02% |
2009 Q3 | 357.45 Million EUR | 0.0% |
2009 FY | 1.42 Billion EUR | -15.95% |
2009 Q4 | 1.42 Billion EUR | 300.0% |
2009 Q2 | 357.45 Million EUR | 0.0% |
2009 Q1 | 357.45 Million EUR | -15.95% |
2008 Q2 | 425.28 Million EUR | 0.0% |
2008 Q1 | 425.28 Million EUR | 26.45% |
2008 FY | 1.7 Billion EUR | 26.45% |
2008 Q3 | 425.28 Million EUR | 0.0% |
2008 Q4 | 425.28 Million EUR | 0.0% |
2007 Q2 | 336.33 Million EUR | 0.0% |
2007 Q1 | 336.33 Million EUR | 10.48% |
2007 Q4 | 336.33 Million EUR | 0.0% |
2007 FY | 1.34 Billion EUR | 10.48% |
2007 Q3 | 336.33 Million EUR | 0.0% |
2006 Q2 | 304.43 Million EUR | 0.0% |
2006 Q3 | 304.43 Million EUR | 0.0% |
2006 Q4 | 304.43 Million EUR | 0.0% |
2006 Q1 | 304.43 Million EUR | -9.01% |
2006 FY | 1.21 Billion EUR | -9.01% |
2005 Q1 | 334.57 Million EUR | 7.55% |
2005 Q2 | 334.57 Million EUR | 0.0% |
2005 Q3 | 334.57 Million EUR | 0.0% |
2005 Q4 | 334.57 Million EUR | 0.0% |
2005 FY | 1.33 Billion EUR | 7.55% |
2004 FY | 1.24 Billion EUR | -3.21% |
2004 Q4 | 311.09 Million EUR | 0.0% |
2004 Q3 | 311.09 Million EUR | 0.0% |
2004 Q2 | 311.09 Million EUR | 0.0% |
2004 Q1 | 311.09 Million EUR | -3.21% |
2003 Q3 | 321.39 Million EUR | 0.0% |
2003 Q1 | 321.39 Million EUR | 36.25% |
2003 Q2 | 321.39 Million EUR | 0.0% |
2003 Q4 | 321.39 Million EUR | 0.0% |
2003 FY | 1.28 Billion EUR | 36.25% |
2002 FY | 943.58 Million EUR | 0.37% |
2002 Q1 | 235.89 Million EUR | 0.0% |
2002 Q2 | 235.89 Million EUR | 0.0% |
2002 Q4 | 235.89 Million EUR | 0.0% |
2002 Q3 | 235.89 Million EUR | 0.0% |
2001 FY | 940.08 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Crossject Société Anonyme | 33.9 Million EUR | -63709.327% |
Safe Orthopaedics SA | 17.79 Million EUR | -121448.576% |
Spineway SA | 7.25 Million EUR | -297984.608% |
Amplitude Surgical SA | 183.43 Million EUR | -11692.926% |
Sartorius Stedim Biotech S.A. | 5.07 Billion EUR | -325.961% |
bonyf N.V. | 411.93 Thousand EUR | -5251201.173% |